Literature DB >> 6410078

Urinary estrogen and serum gonadotropin profiles in women ingesting oral contraceptive steroid formulations with variable estrogen content.

E M Grimes, I E Thompson, M E Taymor.   

Abstract

Entities:  

Keywords:  Age Factors; Biology; Body Temperature; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods--side effects; Data Analysis; Endocrine System; Estrogens--analysis; Ethinyl Estradiol; Examinations And Diagnoses; Family Planning; Gonadotropins--analysis; Hormones; Laboratory Examinations And Diagnoses; Laboratory Procedures; Luteinizing Hormone; Norethindrone Acetate; Oral Contraceptives, Low-dose; Oral Contraceptives--side effects; Physiology; Reproductive Control Agents; Research Methodology

Mesh：

Substances：

Year:  1983        PMID： 6410078      PMCID： PMC2561574     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  15 in total

1.  Effects of estrogen and progesterone on pituitary response to stimulation by luteinizing hormone-releasing factor.

Authors:  I E Thompson; J Arfania; M L Taymor
Journal:  J Clin Endocrinol Metab       Date:  1973-07       Impact factor: 5.958

2.  Morphology of human ovaries after treatment with an injectable long-acting oestrogen-progestogen agent.

Authors:  R Plesner
Journal:  Acta Obstet Gynecol Scand       Date:  1974       Impact factor: 3.636

3.  Ovarian morphology and pituitary gonadotrophins in serum during and after long-term treatment with oral contraceptives.

Authors:  J Starup; J Visfeldt
Journal:  Acta Obstet Gynecol Scand       Date:  1974       Impact factor: 3.636

4.  Effects of a low-oestrogen oral contraceptive on urinary excretion of luteinizing hormone and ovarian steroids.

Authors:  M Elstein; P G Briston; M Jenkins; D Kirk; H Miller
Journal:  Br Med J       Date:  1974-01-05

Review 5.  Current status of human gonadotropin radioimmunoassay.

Authors:  R B Jaffe; A R Midgley
Journal:  Obstet Gynecol Surv       Date:  1969-03       Impact factor: 2.347

6.  Serum estradiol in women ingesting combination oral contraceptive steroids.

Authors:  D R Mishell; I H Thorneycroft; R M Nakamura; Y Nagata; S C Stone
Journal:  Am J Obstet Gynecol       Date:  1972-12-01       Impact factor: 8.661

7.  The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.

Authors:  E M Grimes; I E Thompson; M L Taymor
Journal:  Acta Endocrinol (Copenh)       Date:  1975-08

8.  Profile of a new low dose combination estrogen and progestogen oral contraceptive: a review of nine clinical studies.

Authors:  T B Woutersz
Journal:  J Reprod Med       Date:  1975-09       Impact factor: 0.142

9.  Experience with a new low dose oral contraceptive: norgestimate & ethinyl estradiol.

Authors:  B Rubio-Lotvin; R Gonzales-Ansorena
Journal:  Acta Eur Fertil       Date:  1978-03

10.  Progestational agents and blood coagulation. VIII. Effect of low-dose, alternate-day, estrogen-progestin combinations on blood coagulation factors in man, with a special note on the effect of freezing of blood samples.

Authors:  J L Ambrus; N G Courey; B J Browne; I B Mink; R H Moore; C M Ambrus
Journal:  Am J Obstet Gynecol       Date:  1977-05-15       Impact factor: 8.661
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.